Probing the interactions of macrolide antibiotics with membrane-mimetics by NMR spectroscopy

Journal of Medicinal Chemistry

Volumn 55, Issue 11, 2012, Pages 5632-5636

  Kosol, Simone ^a   Schrank, Evelyne ^a   Krajačić, Mirjana Bukvić ^b   Wagner, Gabriel E ^a   Meyer, N Helge ^a   Göbl, Christoph ^a   Rechberger, Gerald N ^a   Zangger, Klaus ^a   Novak, Predrag ^c  

^a UNIVERSITY OF GRAZ   (Austria)

^b Galapagos Research Center Ltd   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AZAHOMOERYTHROMYCIN; AZITHROMYCIN; AZITHROMYCIN AGLYCONE; CLARITHROMYCIN; DECLADINOSYL AZITHROMYCIN; ERYTHROMYCIN; MACROLIDE; PHOSPHOLIPASE A1; UNCLASSIFIED DRUG;

ARTICLE; BIOMIMETICS; DRUG BINDING; DRUG BIOAVAILABILITY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; LIPIDOSIS; MEMBRANE BINDING; MEMBRANE BIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPID MEMBRANE; PROTEIN LOCALIZATION; SPECTROMETER; SURFACE PROPERTY;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DIFFUSION; MACROLIDES; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANES, ARTIFICIAL; MICELLES; MODELS, MOLECULAR; MOLECULAR MIMICRY; PHOSPHATIDYLSERINES; PHOSPHOLIPASES A1; PHOSPHORYLCHOLINE; SODIUM DODECYL SULFATE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84862272695     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm300647f     Document Type: Article

References (30)

1. Schönfeld, W.; Mutak, S. Macrolide Antibiotics; Birkhäuser Verlag: Basel, 2002; pp 73-95.
2. Culic, O.; Erakovic, V.; Parnham, M. J. Anti-inflammatory effects of macrolide antibiotics Eur. J. Pharmacol. 2001, 429, 209-229
3. Shinkai, M.; Henke, M. O.; Rubin, B. K. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action Pharmacol. Ther. 2008, 117, 393-405
4. Hamada, K.; Mikasa, K.; Yunou, Y.; Kurioka, T.; Majima, T.; Narita, N.; Kita, E. Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer Chemotherapy 2000, 46, 49-61
5. Taylor, W. R.; Richie, T. L.; Fryauff, D. J.; Picarima, H.; Ohrt, C.; Tang, D.; Braitman, D.; Murphy, G. S.; Widjaja, H.; Tjitra, E.; Ganjar, A.; Jones, T. R.; Basri, H.; Berman, J. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia Clin. Infect. Dis. 1999, 28, 74-81
6. Blondeau, J. M.; Tillotson, G. Role of gemifloxacin in the management of community-acquired lower respiratory tract infections Int. J. Antimicrob. Agents 2008, 31, 299-306
7. Loebinger, M. R.; Woilson, R. Bacterial pneumonia Medicine 2008, 36, 285-290
8. Gaynor, M.; Mankin, A. S. Macrolide Antibiotics: Binding Site, Mechanism of Action, Resistance Front. Med. Chem. 2005, 2, 21-35
9. Novak, P.; Barber, J.; Cikos, A.; Arsic, B.; Plavec, J.; Lazarevski, G.; Tepes, P.; Kosutic-Hulita, N. Free and bound state structures of 6- O -methyl homoerythromycins and epitope mapping of their interactions with ribosomes Bioorg. Med. Chem. 2009, 17, 5857-5867
10. Novak, P.; Tatic, I.; Tepes, P.; Kostrun, S.; Barber, J. Systematic approach to understanding macrolide-ribosome interactions: NMR and modeling studies of oleandomycin and its derivatives J. Phys. Chem. A 2006, 110, 572-579
11. Novak, P.; Tomisic, Z. B.; Tepes, P.; Lazarevski, G.; Plavec, J.; Turkalj, G. Conformational analysis of oleandomycin and its 8-methylene-9-oxime derivative by NMR and molecular modelling Org. Biomol. Chem. 2005, 3, 39-47
12. Stepanic, V.; Kostrun, S.; Malnar, I.; Hlevnjak, M.; Butkovic, K.; Caleta, I.; Duksi, M.; Kragol, G.; Makaruha-Stegic, O.; Mikac, L.; Ralic, J.; Tatic, I.; Tavcar, B.; Valko, K.; Zulfikari, S.; Munic, V. Modeling Cellular Pharmacokinetics of 14- and 15-Membered Macrolides with Physicochemical Properties J. Med. Chem. 2011, 54, 719-733
13. Montenez, J. P.; Van Bambeke, F.; Piret, J.; Brasseur, R.; Tulkens, P. M.; Mingeot-Leclercq, M. P. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models Toxicol. Appl. Pharmacol. 1999, 156, 129-140
14. Reasor, M. J.; Kacew, S. Drug-induced phospholipidosis: are there functional consequences? Exp. Biol. Med. (Maywood, NJ, U.S.) 2001, 226, 825-830
15. Anderson, N.; Borlak, J. Drug-induced phospholipidosis FEBS Lett. 2006, 580, 5533-5540
16. Munic, V.; Banjanac, M.; Kostrun, S.; Nujic, K.; Bosnar, M.; Marjanovic, N.; Ralic, J.; Matijasic, M.; Hlevnjak, M.; Erakovic Haber, V. Intensity of macrolide anti-inflammatory activity in J774A.1 cells positively correlates with cellular accumulation and phospholipidosis Pharmacol. Res. 2011, 64, 298-307
17. Grossauer, J.; Kosol, S.; Schrank, E.; Zangger, K. The peptide hormone ghrelin binds to membrane-mimetics via its octanoyl chain and an adjacent phenylalanine Bioorg. Med. Chem. 2010, 18, 5483-5488
18. Kosol, S.; Zangger, K. Dynamics and orientation of a cationic antimicrobial peptide in two membrane-mimetic systems J. Struct. Biol. 2010, 170, 172-179
19. Respondek, M.; Madl, T.; Göbl, C.; Golser, R.; Zangger, K. Mapping the orientation of helices in micelle-bound peptides by paramagnetic relaxation waves J. Am. Chem. Soc. 2007, 129, 5228-5234
20. Zangger, K.; Respondek, M.; Göbl, C.; Hohlweg, W.; Rasmussen, K.; Grampp, G.; Madl, T. Positioning of micelle-bound peptides by paramagnetic relaxation enhancements J. Phys. Chem. 2009, 113, 4400-4406
21. Göbl, C.; Dulle, M.; Hohlweg, W.; Grossauer, J.; Falsone, S. F.; Glatter, O.; Zangger, K. Influence of phosphocholine alkyl chain length on peptide-micelle interactions and micellar size and shape J. Phys. Chem. 2010, 114, 4717-4724
22. Kallick, D. A.; Tessmer, M. R.; Watts, C. R.; Li, C. Y. The use of dodecylphosphocholine micelles in solution NMR J. Magn. Reson. B 1995, 109, 60-65
23. Franzmann, M.; Otzen, D.; Wimmer, R. Quantitative use of paramagnetic relaxation enhancements for determining orientations and insertion depths of peptides in micelles ChemBioChem 2009, 10, 2339-2347
24. Pintacuda, G.; Otting, G. Identification of protein surfaces by NMR measurements with a paramagnetic Gd(III) chelate J. Am. Chem. Soc. 2002, 124, 372-373
25. Matsumori, N.; Morooka, A.; Murata, M. Detailed description of the conformation and location of membrane-bound erythromycin a using isotropic bicelles J. Med. Chem. 2006, 49, 3501-3508
26. Tyteca, D.; Schanck, A.; Dufrene, Y. F.; Deleu, M.; Courtoy, P. J.; Tulkens, P. M.; Mingeot-Leclercq, M. P. The macrolide antibiotic azithromycin interacts with lipids and affects membrane organization and fluidity: studies on Langmuir-Blodgett monolayers, liposomes and J774 macrophages J. Membr. Biol. 2003, 192, 203-215
27. Kubo, M.; Hostetler, K. Y. Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1 Biochemistry 1985, 24, 6515-6520
28. Drenckhahn, D.; Kleine, L.; Lullmann-Rauch, R. Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs Lab. Invest. 1976, 35, 116-123
29. Lullmann, H.; Lullmann-Rauch, R.; Wassermann, O. Lipidosis induced by amphiphilic cationic drugs Biochem. Pharmacol. 1978, 27, 1103-1108
30. Hostetler, K. Y.; Reasor, M.; Yazaki, P. J. Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes J. Biol. Chem. 1985, 260, 215-219